Companies: 10,795·Total market cap: $144.5T
Veracyte, Inc.

Veracyte, Inc.

VCYTNASDAQHealthcare● Active
$47.27
$-1.46(-3.00%)
Market Cap$3.8B
P/E Ratio
52W High$50.71
52W Low$22.61

Veracyte, Inc. (VCYT) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

vcyt · stock forecast · 20 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 20 Wall Street analysts in the past 3 months

SellBuy

Buy

20 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
13
Hold
6
Sell
1
Strong Sell
0
Total: 20 · Buy rate: 65.0%

12-Month Price Target

High

$57.00

Consensus

$47.60

+0.7% upside

Low

$37.00

Median: $50 · Last Close: $47.27

The Veracyte, Inc. (VCYT) analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month VCYT price target is $47.60, representing +0.7% upside from the current price of $47.27.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $48 (0.7%)

Consensus Target

$47.60

0.7% upside

High Target

$57

20.6%

Low Target

$37

-21.7%

Current Price

$47.27

as of today

Based on analyst price targets, the VCYT stock price prediction for the next 12 months ranges from $37 to $57. The consensus VCYT price forecast of $47.60 implies 0.7% upside from the current price of $47.27.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$49.635.00%

1-day model range: $49.12–$50.15. Peak: $50.15 (+5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$39-17.7%
2028$35-26.5%
2029$33-31.2%
2030$31-33.8%
2031-35.4%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

71%8%21%
10Buy
1Neutral
3Sell
RSI (14)66.8Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · VCYT · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$48.49SELL
MA 10$47.36SELL
MA 20$44.36BUY
MA 50$37.87BUY
MA 100$37.10BUY
MA 200$37.64BUY
Current $VCYT · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$48.07SELL
EMA 10$47.12BUY
EMA 20$44.68BUY
EMA 50$40.44BUY
EMA 100$38.54BUY
EMA 200$37.07BUY
Current $VCYT · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Needham2026-06-01
Maintains
BuyBuy
Needham2026-05-28
Maintains
BuyBuy
UBS2026-05-06
Maintains
BuyBuy
Canaccord Genuity2026-05-06
Maintains
HoldHold
Canaccord Genuity2026-04-20
Maintains
HoldHold
Needham2026-04-01
Maintains
BuyBuy
Guggenheim2026-03-30
Maintains
BuyBuy
Morgan Stanley2026-03-06
Maintains
UnderweightUnderweight
Needham2026-02-26
Maintains
BuyBuy
Guggenheim2026-01-05
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Veracyte, Inc. (VCYT) stock. Of the recent 103 rating actions, 2 were upgrades and 6 were downgrades. 20 analysts currently cover VCYT.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

VCYT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$587M

↓ 18.1% YoY

Revenue Next Year

$655M

↑ 11.5% YoY

EPS This Year

$1.83

EPS Next Year

$1.90

↑ 3.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast VCYT EPS of $1.83 for the current fiscal year, based on estimates from 6 analysts. The VCYT revenue forecast is $587M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The VCYT stock forecast is supported by two independent data sources: analyst consensus ratings from 20 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus VCYT price target is $47.60 (+0.7% upside), with an analyst consensus of Buy.

The VCYT short-term stock prediction for tomorrow is $49.63 (+5.00%). The VCYT stock price prediction for 2027 estimates an average of $39. The VCYT stock prediction for 2030 projects a range of $28–$35.

Veracyte, Inc. trades on NASDAQ under the ticker VCYT. The VCYT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 65% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

VCYT forecast · 8 questions

According to 20 Wall Street analysts, the average 12-month VCYT price target is $47.60, with a high forecast of $57.00 and a low of $37.00. The median price target is shown in the chart above when available. This implies +0.7% potential upside from the current price of $47.27.

VCYT price targetWhat is VCYT price targetVCYT analyst price targetVCYT 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.